Spinal Stabilization Technologies enrolled its first U.S. patient in the Investigational Device Exemption clinical trial for its PerQdisc Nucleus Replacement Device.
Spinal Stabilization Technologies enrolled its first U.S. patient in the Investigational Device Exemption clinical trial for its PerQdisc Nucleus Replacement Device.